CA2286301A1 - Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques - Google Patents
Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques Download PDFInfo
- Publication number
- CA2286301A1 CA2286301A1 CA 2286301 CA2286301A CA2286301A1 CA 2286301 A1 CA2286301 A1 CA 2286301A1 CA 2286301 CA2286301 CA 2286301 CA 2286301 A CA2286301 A CA 2286301A CA 2286301 A1 CA2286301 A1 CA 2286301A1
- Authority
- CA
- Canada
- Prior art keywords
- phage
- peptide
- pviii
- mbp
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2286301 CA2286301A1 (fr) | 1999-11-01 | 1999-11-01 | Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2286301 CA2286301A1 (fr) | 1999-11-01 | 1999-11-01 | Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2286301A1 true CA2286301A1 (fr) | 2001-05-01 |
Family
ID=4164379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2286301 Abandoned CA2286301A1 (fr) | 1999-11-01 | 1999-11-01 | Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2286301A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012001004A1 (fr) * | 2010-07-02 | 2012-01-05 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Vaccin à base de fimh contre les infections du système urinaire |
EP2738256A2 (fr) * | 2011-07-26 | 2014-06-04 | Universidad Nacional Autónoma De México | Utilisation du peptide gk-1 exprimé dans le phage filamenteux m13 pour l'élaboration de produits pharmaceutiques qui augmentent l'efficacité de la réponse immunitaire induite par des antigènes vaccinaux ou pathogènes |
USRE45968E1 (en) | 2005-12-27 | 2016-04-12 | Sigma Tau Industrie Farmaceutiche Riunite S.P.A. | Vector for efficient selection and/or maturation of an antibody and uses thereof |
-
1999
- 1999-11-01 CA CA 2286301 patent/CA2286301A1/fr not_active Abandoned
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE45968E1 (en) | 2005-12-27 | 2016-04-12 | Sigma Tau Industrie Farmaceutiche Riunite S.P.A. | Vector for efficient selection and/or maturation of an antibody and uses thereof |
WO2012001004A1 (fr) * | 2010-07-02 | 2012-01-05 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Vaccin à base de fimh contre les infections du système urinaire |
JP2013530707A (ja) * | 2010-07-02 | 2013-08-01 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | ***症(uti)ワクチン |
EP2738256A2 (fr) * | 2011-07-26 | 2014-06-04 | Universidad Nacional Autónoma De México | Utilisation du peptide gk-1 exprimé dans le phage filamenteux m13 pour l'élaboration de produits pharmaceutiques qui augmentent l'efficacité de la réponse immunitaire induite par des antigènes vaccinaux ou pathogènes |
EP2738256A4 (fr) * | 2011-07-26 | 2015-04-15 | Univ Nac Autónoma De México | Utilisation du peptide gk-1 exprimé dans le phage filamenteux m13 pour l'élaboration de produits pharmaceutiques qui augmentent l'efficacité de la réponse immunitaire induite par des antigènes vaccinaux ou pathogènes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bao et al. | Phage-based vaccines | |
US6964769B2 (en) | Molecular antigen array | |
Ren et al. | Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4 | |
Meola et al. | Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. | |
US5837268A (en) | GnRH-leukotoxin chimeras | |
Van Houten et al. | Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide | |
EP1135162B1 (fr) | Presentation moleculaire ordonnee d'allergenes, procede de preparation et utilisation | |
van Houten et al. | Engineering filamentous phage carriers to improve focusing of antibody responses against peptides | |
JP3993605B2 (ja) | 合成ペプチド免疫原のための免疫刺激因子としての人工的tヘルパー細胞エピトープ | |
US5723129A (en) | GnRH-leukotoxin chimeras | |
US6261569B1 (en) | Retro-, inverso- and retro-inverso synthetic peptide analogues | |
KR100222163B1 (ko) | 캡시드를 형성하고 시스테인 변형된 키메라 ms-2 코트 단백질 | |
Minenkova et al. | Design of specific immunogens using filamentous phage as the carrier | |
JP2858848B2 (ja) | B型肝炎ウイルスコア抗原粒子 | |
US6171591B1 (en) | Recombinant nodavirus compositions and methods | |
US7115266B2 (en) | Angiotensin peptide-carrier conjugates and uses thereof | |
JP2015205881A5 (fr) | ||
Perham et al. | Engineering a peptide epitope display system on filamentous bacteriophage | |
JPH0768266B2 (ja) | ネコ科白血病ウイルスワクチン | |
NZ220027A (en) | Antigens or haptens coupled to escherichia coli outer membrane proteins for enhancement of immune response | |
US5763574A (en) | HIV-specific synthetic antigens and their use | |
JP3238396B2 (ja) | 担体結合組換えタンパク質、その製造方法並びに免疫原及びワクチンとしての使用 | |
Santoni et al. | Plant virus nanoparticles for vaccine applications | |
CA2286301A1 (fr) | Bacteriophage filamenteux utilise comme structure multivalente pour le couplage des peptides synthetiques | |
AU634837B2 (en) | Malaria vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |